Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Central Nervous System Neoplasms 4Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Prostatic Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Teratoma 1Solitary Fibrous Tumor, Pleural 1Rhabdoid Tumor 1Penile Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Mesothelioma, Malignant 1Liposarcoma 1Leiomyosarcoma 1Inflammatory Breast Neoplasms 1Glioma 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 5Epirubicin 4Docetaxel 4pegfilgrastim 2Trastuzumab 2Radiotherapy 2Filgrastim 2Doxorubicin 2Bevacizumab 2Taxes 1Surgical Procedures, Operative 1Paclitaxel 1Neoadjuvant Therapy 1Microarray Analysis 1Lapatinib 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Inflammatory Breast Neoplasms × Neoadjuvant Therapy × Clear all
NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
1,856 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡